Concepedia

Denise Blum‐Kaelin

DB

Statistics

Publications

9

Citations

529

H-Index

9

Active since

1992

Affiliations

Roche (Switzerland)(Current)

Board of the Swiss Federal Institutes of Technology

Denise Blum‐Kaelin is an author at Roche (Switzerland) specializing in pharmacology, ligand binding, and pharmacy.

Publications per year

1992–2010

9

Publications

9

Two novel human pancreatic lipase related proteins, hPLRP1 and hPLRP2. Differences in colipase dependence and in lipase activity.

Thomas Giller, Petra Buchwald, Denise Blum‐Kaelin et al. · Journal of Biological Chemistry · 1992 · 160 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14

Modulating cholesteryl ester transfer protein activity maintains efficient pre-β-HDL formation and increases reverse cholesterol transport

Eric J. Niesor, Christine Magg, Naoto Ogawa et al. · Journal of Lipid Research · 2010 · 152 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Discovery of tetrahydro-cyclopenta[b]indole as selective LXRs modulator

Hassen Ratni, Denise Blum‐Kaelin, Henrietta Dehmlow et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +8

Endothelin-Converting Enzyme Inhibition Ameliorates Angiotensin II–Induced Cardiac Damage

Dominik N. Müller, Alexander Mullally, Ralf Dechend et al. · Hypertension · 2002 · 40 citations · Full text

Medicine, Cardiology, Pharmacology +15

Endothelin-Converting Enzyme-1 Inhibition and Growth of Human Glioblastoma Cells

Yann Berger, Henrietta Dehmlow, Denise Blum‐Kaelin et al. · Journal of Medicinal Chemistry · 2004 · 37 citations · Full text

Medicine, Oncology, Pharmacology +10

1–5 of 9